ADC Bio: Biotech may 'hold the key' to innovation adoption
CDMOs need to respond to biotech innovation at an R&D level to improve efficiency in antibody-drug conjugate manufacturing, says ADC Bio.
Archives for June 8, 2018
GE grows FlexFactory presence in China with another cell therapy plant deal
GE Healthcare has announced plans to install its second FlexFactory manufacturing platform for cell therapy, this time at Xiangxue Pharmaceutical’s site in Guangzhou, China.
Microbiome start-up will receive up to €454 million in upfront and milestone payments
Gutsy move: Microbiome spin-out seals half-billion-dollar deal with pharma giant
UK-based Microbiotica will collaborate with Roche-owned biotechnology group Genentech in the hunt for new microbiome-based therapeutics and biomarkers for its inflammatory bowel disease (IBD) pipeline.